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MaOBJECTIVES This study sought to investigate sex-related differences in treatment and outcomes in elderly patients
with non–ST-segment elevation acute coronary syndromes (NSTEACS).
BACKGROUND Female sex and older age are usually associated with worse outcome in NSTEACS. The Italian Elderly
ACS study enrolled NSTEACS patients aged 75 years of age and older in a randomized trial comparing an early aggressive
with an initially conservative strategy and in a registry of patients with $1 exclusion criteria of the trial.
METHODS We compared sexes in the pooled populations of the trial and registry.
RESULTS A total of 645 patients (313 from the trial and 332 from the registry), including 301women (47%), were enrolled.
Womenwere slightlyolder thanmen (82.1 5.0yearsvs.81.24.5years; p¼0.02), had lowerhemoglobin levels (12.5 1.6
g/dl vs. 13.3 1.9 g/dl; p< 0.001), and underwent fewer coronary revascularizations during the index admission (37.2% vs.
45.0%;p¼0.04). In-hospital adverse event rateswere similar in both sexes; severebleedingwasuncommon (0.3%vs.0%).
The 1-year primary endpoint (composite of death, nonfatal myocardial infarction, disabling stroke, cardiac rehospitalization,
and severe bleeding) occurred less often in women (27.6% vs. 38.7%; p < 0.01). Women not undergoing revascularization
showed a 3-fold higher mortality, both in-hospital (8.5% vs. 2.7%; p ¼ 0.05) and at 1 year (21.6% vs. 8.1%; p ¼ 0.002).
CONCLUSIONS Elderly women had a similar in-hospital outcome and better 1-year outcome compared with men.
Coronary revascularization in women was associated with lower 1-year mortality, without an increase in severe
bleeding. Elderly women with NSTEACS should always be considered for early revascularization. (J Am Coll Cardiol Intv
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ABBR EV I A T I ON S
AND ACRONYMS
ACS = acute coronary
syndrome(s)
CI = conﬁdence interval
ECG = electrocardiogram
HR = hazard ratio
MI = myocardial infarction
NSTEACS = non–ST-segment
elevation acute coronary
syndrome(s)
NSTEMI = non–ST-segment
elevation myocardial infarction
PCI = percutaneous coronary
intervention
RCT = randomized controlled
trial
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792ACS study consisted of an RCT comparing an
early aggressive with an initially conserva-
tive strategy in patients 75 years of age and
older with non–ST-segment elevation ACS
(NSTEACS) (4), and a parallel registry of
patients who fulﬁlled the inclusion criteria of
the trial but had at least 1 exclusion criterion.
The aim of the present study was to inves-
tigate sex-related differences in the pooled
populations of the study.
METHODS
STUDY DESIGN AND POPULATION. Details
regarding study design and population of the
Italian Elderly ACS were previously pub-
lished (4,5). The primary endpoint was theTABLE 1 Baseline Proﬁle, Treatment Characteristics, In-Hospitalcomposite of all-cause mortality, nonfatal myocardial
infarction (MI), disabling stroke, and repeat hos-
pitalization for cardiovascular causes or severe
bleeding within 12 months.and Follow-Up Adverse Events of Patients Enrolled in Either Trial
or Registry, According to Sex
Male
(n ¼ 344)
Female
(n ¼ 301) p Value
Age, yrs 81.2  4.5 82.1  5.0 0.02
Diabetes 125 (36.3) 106 (35.2) 0.76
eGFR, ml/min 47.2  16.9 47.0  17.9 0.91
Elevated troponin levels 257 (74.7) 226 (75.1) 0.91
Ischemic ECG changes 272 (79.1) 234 (77.7) 0.68
Ejection fraction, % 46  11 49  10 <0.001
Hemoglobin levels, g/dl 13.3  1.9 12.5  1.6 <0.001
Trial 157 (50.2) 156 (49.8) 0.11*
Registry 187 (56.3) 145 (43.7) 0.11*
Aspirin 317 (92.2) 277 (92.0) 0.95
Thienopyridines 294 (85.5) 252 (83.7) 0.54
Coronary angiography 212 (61.6) 167 (55.5) 0.11
PCI 140 (40.7) 104 (34.6) 0.11
CABG 15 (4.4) 8 (2.7) 0.24
PCI or CABG 155 (45.0) 112 (37.2) 0.04
In-hospital events† 15 (4.4) 24 (8.0) 0.05
Death 13 (3.8) 19 (6.3) 0.14
TIMI major bleeding 0 1 (0.3) 0.28
Nondisabling stroke 0 1 (0.3) 0.28
Myocardial infarction 3 (0.9) 6 (2.0) 0.23
Primary endpoint at 1 yr† 133 (38.7) 83 (27.6) <0.01
Death 70 (20.3) 50 (16.6) 0.22
Cardiovascular death 57 (16.6) 40 (13.3) 0.24
Myocardial infarction 27 (7.8) 21 (7.0) 0.67
Cardiac rehospitalization 55 (16.0) 28 (9.3) 0.01
Severe bleeding 2 (0.6) 3 (1.0) 0.55
Disabling stroke 0 1 (0.3) 0.28
Values are mean  SD or n (%). *Trial versus registry. †The sum of each category’s
events does not add up to the total because of a nonhierarchical reporting.
CABG ¼ coronary artery bypass graft; ECG ¼ electrocardiogram; eGFR¼ esti-
mated glomerular ﬁltration rate; PCI ¼ percutaneous coronary intervention;
TIMI ¼ Thrombolysis In Myocardial Infarction.
SEE PAGE 797STATISTICAL ANALYSIS. Results are presented as
number and percentage for categorical variables, and
mean  SD for continuous data. Comparison of cate-
gorical variables between groups was performed using
the chi-square test or the Fisher exact test, whereas
the Student t test was used for continuous variables.
To investigate the sex effect on the primary endpoint
in the trial and registry population, we pooled all data
using a meta-analytical approach, assuming a series of
different treatment effects because of different base-
line characteristics. We applied the random-effects
model to account for the variance within each popu-
lation and between trial and registry. Survival plots
and log rank tests were used to determine and
compare the 1-year cumulative risk of events accord-
ing to sex and age. The independent predictors of the
1-year primary composite endpoint were evaluated
using the Cox proportional hazards model.
RESULTS
PATIENT POPULATION. The study population con-
sisted of 645 patients: 313 in the RCT and 332 in the
registry. The overall heterogeneity of the populations
of the trial and registry was very low (I2 ¼ 0%). When
comparing the 301 women with the 344 men enrolled
in the pooled populations, the baseline clinical char-
acteristics were remarkably similar, with only few
statistically signiﬁcant differences, including older
age, lower hemoglobin levels, and higher leftventricular ejection fraction in women (Table 1). The
key variables of ischemic electrocardiogram (ECG)
changes and increased troponin levels were identical
in men and women.
Women had nonsigniﬁcantly lower rates of coro-
nary angiography, but signiﬁcantly lower rates of
coronary revascularization (37% vs. 45%; p ¼ 0.04)
(Table 1). Conversely, medical treatment did not
differ between sexes. More than 70% of all in-
terventions were performed via the radial artery.
CLINICAL OUTCOMES. No signiﬁcant differences
between sexes were observed regarding in-hospital
adverse events, including death, MI, stroke, and
severe bleeding (Table 1). Only 1 woman experienced
a severe bleeding event during hospitalization (0.3%).
The rates of overall and cardiovascular death,
MI, stroke, and severe bleeding were also similar be-
tween sexes at 1-year follow-up, but the rate of
rehospitalization for cardiovascular causes was
FIGURE 1 Cumulative Primary Endpoint Rate in Trial and Registry
Chart shows the unadjusted risk ratio and 95% conﬁdence interval (CI) according to sex. The populations of the trial and registry did not show
signiﬁcant heterogeneity.
FIGURE 2 Kaplan-Meier Survival Curves for the Primary Endpoint Stratiﬁed by Sex
Kaplan-Meier survival curves for the primary endpoint (death, myocardial infarction,
disabling stroke, and repeat hospitalization for cardiovascular causes or bleeding) in
women versus men.
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793almost one-half for women (9.3% vs. 16.0%; p ¼ 0.01),
thus driving the primary endpoint toward a signiﬁ-
cantly lower rate (27.6% vs. 38.7%; p < 0.01) (Table 1,
Figure 1). The Kaplan-Meier freedom from the primary
endpoint at 1 year was 73  2% for women versus
67  2% for men (p < 0.01) (Figure 2).
Male sex was an independent predictor of the pri-
mary endpoint (hazard ratio [HR]: 1.59, 95% conﬁ-
dence interval [CI]: 1.18 to 2.15; p ¼ 0.003), together
with older age (HR: 1.04 per year, 95% CI: 1.01 to 1.07;
p ¼ 0.016), lower left ventricular ejection fraction
(HR: 1.04 per percentage point, 95% CI: 1.02 to 1.05;
p < 0.001), and lower hemoglobin levels (HR: 1.16 per
g/dl, 95% CI: 1.07 to 1.25; p < 0.001).
DIFFERENCES BETWEEN TRIAL AND REGISTRY.
Women enrolled in the registry had worse risk pro-
ﬁles compared with women enrolled in the trial, with
signiﬁcantly older age, lower estimated glomerular
ﬁltration rate, and higher rates of increased troponin
levels and of ischemic ECG changes (Table 2). Coro-
nary angiography was performed in 55% of women in
both the trial and registry; however, the rate of
revascularization was lower in the registry (33.3%
vs. 41.4%; p ¼ 0.15). Clinical outcomes were similar
between trial and registry populations both in-
hospital and at 1 year (Table 2).
When comparing the 226 women with non–ST-
segment elevation myocardial infarction (NSTEMI)
with the 75 women with unstable angina enrolled in
the trial and registry, no signiﬁcant differences were
observed regarding baseline proﬁle and treatment
characteristics, except for worse renal function (esti-
mated glomerular ﬁltration rate, 44.1 18.3 ml/min vs.
52.0  20.4 ml/min; p < 0.01). Coronary angiography
and revascularization rates were 56.6% and 38.9% for
NSTEMI and 52.0% and 32.0% for unstable angina.
In-hospital clinical outcomes were similar, but the
1-year primary endpoint occurred more frequently for
NSTEMI (30.1% vs. 20.0%; p ¼ 0.09), mainly driven by
higher mortality (19.0% vs. 9.3%; p ¼ 0.05).REVASCULARIZATIONVERSUSNONREVASCULARIZATION.
When comparing the 111 women who underwent
any kind of coronary revascularization during the
index admission with the 190 women who were
not revascularized, the latter had a signiﬁcantly
worse risk proﬁle, including older age and lower
estimated glomerular ﬁltration rate (Table 3). In-
hospital mortality was signiﬁcantly higher among
nonrevascularized women (8.5% vs. 2.7%; p ¼ 0.05),
whereas the MI rate was higher in the revascularized
group (2.7% vs. 1.6%; p ¼ 0.51) (Table 3). There were
only 1 severe bleeding event and 1 stroke, and both
occurred in the nonrevascularized group. At 1-year
follow-up, nonrevascularized women had a 3-fold
higher mortality rate (21.6% vs. 8.1%; p ¼ 0.002),
mainly cardiovascular (17.3% vs. 6.3%; p ¼ 0.002). No
TABLE 2 Baseline Proﬁle, Treatment Characteristics, In-Hospital and
Follow-up Adverse Events of Female Patients Enrolled in the Trial and
the Registry
Trial
(n ¼ 156)
Registry
(n ¼ 145) p Value
Age, yrs 81.5  4.7 82.8  5.3 0.02
Diabetes 58 (37.2) 48 (33.1) 0.46
eGFR, ml/min 51.6  16.7 42.0  17.9 <0.01
Increased troponin levels 97 (62.2) 129 (89.0) <0.01
Ischemic ECG changes 99 (63.5) 135 (93.1) <0.01
Ejection fraction, % 50  10 48  11 0.18
Hemoglobin levels, g/dl 12.6  1.5 12.3  1.8 0.16
Coronary angiography 86 (55.1) 80 (55.2) 0.99
PCI 57 (39.3) 47 (30.1) 0.09
CABG 5 (3.2) 3 (2.1) 0.54
In-hospital events* 13 (8.3) 11 (7.6) 0.81
Death 9 (5.8) 10 (6.9) 0.69
TIMI major bleeding 1 (0.6) 0 0.33
Nondisabling stroke 1 (0.6) 0 0.33
Myocardial infarction 5 (3.2) 1 (0.7) 0.20
Primary endpoint at 1 yr* 38 (24.4) 45 (31.0) 0.19
Death 21 (13.5) 29 (20.0) 0.13
Cardiovascular death 18 (11.5) 22 (15.2) 0.35
Myocardial infarction 15 (9.6) 6 (4.1) 0.06
Cardiac rehospitalization 12 (7.7) 16 (11.0) 0.32
Severe bleeding 3 (1.9) 0 0.09
Disabling stroke 0 1 (0.7) 0.30
Values are mean  SD or n (%). *The sum of events does not add up to the total because of non-
hierarchical reporting.
Abbreviations as in Table 1.
TABLE 3 Baseline Proﬁle, Treatment Characteristics, In-Hospital and Follow-
Up Adverse Events of Women Enrolled in Either Trial or Registry According to
the Occurrence of Revascularization During the Index Hospitalization
Revascularization
(n ¼ 112)
No Revascularization
(n ¼ 189) p Value
Age, yrs 81.0  4.4 82.7  5.3 <0.01
Diabetes 40 (35.7) 66 (34.9) 0.89
eGFR, ml/min 48.8  18.5 44.3  19.3 0.05
Increased troponin levels 88 (78.6) 138 (73.0) 0.28
Ischemic ECG changes 90 (80.4) 144 (76.2) 0.40
Ejection fraction, % 51  10 48  10 0.07
Hemoglobin levels, g/dl 12.6  1.4 12.4  1.7 0.16
In-hospital events* 6 (5.4) 18 (9.5) 0.19
Death 3 (2.7) 16 (8.5) 0.05
TIMI major bleeding 0 1 (0.5) 0.55
Nondisabling stroke 0 1 (0.5) 0.55
Myocardial infarction 3 (2.7) 3 (1.6) 0.51
Primary endpoint at 1 yr* 19 (17.0) 64 (33.9) 0.002
Death 9 (8.1) 41 (21.6) 0.002
Cardiovascular death 7 (6.3) 33 (17.3)
Myocardial infarction 5 (4.5) 16 (8.5) 0.18
Cardiac rehospitalization 9 (8.0) 19 (10.1) 0.56
Severe bleeding 0 3 (1.6) 0.18
Disabling stroke 1 (0.9) 0 0.19
Values are mean  SD or n (%). *The sum of events does not add up to the total because of non-
hierarchical reporting.
Abbreviations as in Table 1.
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794signiﬁcant differences were observed concerning
other adverse events.DISCUSSION
The main ﬁndings of the present study are the
following: 1) when sex-related difference in age is
eliminated by inclusion criterion, the baseline clinical
characteristics are remarkably similar between sexes,
including renal function, diabetes, ischemic ECG
changes, and troponin levels, whereas a signiﬁcantly
lower ejection fraction in men probably reﬂects a
longer ischemic history, with previous revascul-
arizations; 2) despite these similarities, coronary
revascularization is still signiﬁcantly performed less in
women; 3) the rate of in-hospital adverse events is
similar between sexes; 4) the 1-year outcome was
signiﬁcantly worse in men, driven by a higher rate of
cardiac rehospitalizations (mainly congestive heart
failure); and 5) women who are not revascularized
have a 3-fold higher in-hospital and 1-year mortality
rate compared with revascularized women.
PATIENT POPULATION. The Italian Elderly ACS study
included one of the largest prospectively enrolled
populations of truly elderly ACS patients (6,7), with a
very low heterogeneity between trial and registry.
In the pooled population, women underwent
signiﬁcantly fewer revascularizations compared with
men; this difference derives from a slightly lower rate
of coronary angiography, but also from a lower rate of
revascularization after angiography. Notably, the
rates of in-hospital adverse events were similar be-
tween sexes. This ﬁnding is in contrast with previous
reports of higher in-hospital mortality and morbidity
in women older than 75 years of age undergoing pri-
mary percutaneous coronary intervention (PCI) (8). In
the broader setting of NSTEACS, our study shows a
similar short-term outcome between sexes and an
even better 1-year clinical outcome in women, ques-
tioning the idea that elderly women may be too fragile
to tolerate an invasive therapeutic approach. In fact, in
a recent report describing age-speciﬁc sex differences
in in-hospital mortality after an ACS, mortality dif-
ference by sex decreased with age, with women hav-
ing marginally better outcomes at 70 years of age and
older in NSTEMI (9). Similarly, no sex difference in
1-year mortality was observed in the older age group
of a large population of primary PCI patients (10). A
possible explanation for these ﬁndings may be the
longer history of coronary disease in elderly men
compared with women, as also shown in our study.
A surprising ﬁnding in our study was the low rate
of in-hospital severe bleeding in women. We believe
PERSPECTIVES
WHAT IS KNOWN? Female sex and older age are usually
associated with worse outcome in NSTEACS.
WHAT IS NEW? In a large population of elderly NSTEACS
patients, we observed that women had a short-term outcome
similar to that in men and a better 1-year clinical outcome.
Revascularization in women was associated with markedly lower
early and late mortality.
WHAT IS NEXT? Elderly women with an NSTEACS should
receive the same diagnostic and therapeutic approach as men.
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795that the use of the radial artery access in more than
70% of the patients may explain such a ﬁnding, at
variance with former studies describing female sex as
a risk factor for bleeding in ACS (11) and for PCI (12),
although such a sex-related risk decreased over the
past years. Our study is in agreement with the Acute
Coronary Syndrome Prospective Audit (ACACIA) reg-
istry, in which age 75 years and older was not a risk
factor for bleeding (13).
As expected, women enrolled in the registry
showed a signiﬁcantly worse proﬁle compared with
women enrolled in the trial. However, the rates of
coronary angiography and revascularization did not
differ signiﬁcantly between trial and registry. More-
over, the prevalence of in-hospital and 1-year adverse
events was comparable between groups, showing that
the Italian ACS Elderly RCT did not enroll a low-risk
population.
REVASCULARIZATION VERSUS NO REVASCULARIZATION.
Large NSTEACS registries showed that patients older
than 75 years of age are less likely to receive an early
invasive strategy and be revascularized, although
their absolute accrued beneﬁt appears to be the
highest (6,13). In particular, in the ACACIA, only 30%
of elderly patients underwent revascularization. In
the present study, the rates of coronary angiography
and revascularization are the highest reported in the
literature for elderly patients, being 56% and 37% in
women and 62% and 45% in men, respectively. This
ﬁnding conﬁrms the trend toward a more appropriate
management of elderly patients with an NSTEACS,
which should not differ from that of younger patients
and should include coronary angiography and revas-
cularization, whenever appropriate. In fact, myocar-
dial revascularization during the index admission was
strongly associated with a better 1-year clinical
outcome in elderly women. In the Italian Elderly ACS
trial, an early aggressive approach was associated
with a clinical beneﬁt only in patients with increased
troponin at baseline. In the present analysis,
the addition of the registry data, with an 89% rate
of increased troponin on admission, enhanced
the correlation between early revascularization and
better 1-year prognosis; in particular, women under-
going revascularization showed a 3-fold lower car-
diac mortality at 1-year compared with those not
revascularized.STUDY LIMITATIONS. The present analysis has the
obvious limitation of pooling together patients
enrolled in the RCT and in the parallel registry,
although the 2 populations were quite homogeneous.
Therefore, despite the fact that coronary revas-
cularization was associated with better survival at
multivariable analysis, a number of clinical and
angiographic characteristics of the patients may have
impacted clinical decision-making. In addition, as all
patients enrolled in the trial and registry had to be
able to sign an informed consent, our data may not
apply to the frailest of elderly patients.
CONCLUSIONS
Our study shows that elderly women presenting with
an NSTEACS have a short-term outcome similar to
that in men and a better 1-year clinical outcome.
Moreover, women undergoing coronary revasculari-
zation had only one-third of the mortality rate
observed in women not undergoing revasculariza-
tion, without the higher rates of severe bleeding.
Therefore, elderly women with an NSTEACS should
not be denied an evidence-based diagnostic and
therapeutic approach because of an alleged excess in
in-hospital mortality and severe bleeding.
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